China Isotope & Radiation Corp.

As of June 30, 2026, China Isotope & Radiation Corp. carries a market capitalization of 5.60B, placing it among publicly traded companies globally. Its enterprise value stands at 9.47B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

China Isotope & Radiation Corp.'s next confirmed earnings release is scheduled for March 31, 2027.

As of June 30, 2026, China Isotope & Radiation Corp. has 319.87M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, China Isotope & Radiation Corp. maintains a current ratio of 1.80, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, China Isotope & Radiation Corp.'s stock has declined approximately 32.22% over the past 52 weeks. The 50-day moving average sits at 14.47, while the 200-day moving average is 18.22.

As of June 30, 2026, China Isotope & Radiation Corp. holds 2.95B in cash and equivalents against 3.31B in total debt, resulting in a net debt position of 305.30M. Total book value stands at 6.14B, with working capital of 4.92B providing operational flexibility.